SCHEMBL6205439

SCHEMBL6205439

COC1CN(c2ccccc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 3/20 0.44
CRBN Q96SW2 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
POLB P06746 2/20 0.44
ALDH1A1 P00352 2/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
GRM2 Q14416 4/20 0.40
ALOX5 P09917 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15552907 0.82 DDB1 (0.56) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL5084480 0.80 DDB1 (0.47) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL27870724 0.76 GRM2 (0.44) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL6206756 0.73 DDB1 (0.41) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL13818358 0.71 MEN1 (0.48) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL8045387 0.71 MEN1 (0.48) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL8790545 0.70 MEN1 (0.48) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL8495437 0.70 ATM (0.51) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL8495439 0.70 ATM (0.51) DDB1CRBNMEN1KMT2ANPC1
SCHEMBL7209209 0.70 HPGD (0.46) DDB1CRBNMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521742-A1 DIPHENYLAZETIDINONE DERIVATIVES FOR TREATING DISORDERS OF THE LIPID METABOLISM AstraZeneca AB (SE) 2005-04-13 EP disclosed
WO-2004005247-A1 DIPHENYLAZETIDINONE DERIVATIVES FOR TREATING DISORDERS OF THE LIPID METABOLISM ASTRAZENECA AB (SE) 2004-01-15 WO disclosed
EP-0944594-A4 INHIBITORS OF THE ENZYMATIC ACTIVITY OF PSA LILLY CO ELI (US) 2000-05-03 EP disclosed
EP-0944594-A1 INHIBITORS OF THE ENZYMATIC ACTIVITY OF PSA ELI LILLY AND COMPANY (US) 1999-09-29 EP disclosed
WO-1998025895-A1 INHIBITORS OF THE ENZYMATIC ACTIVITY OF PSA ELI LILLY AND COMPANY (US) 1998-06-18 WO disclosed